Clinical Trial Update: Aflibercept for Relapsed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial update of aflibercept for relapsed multiple myeloma; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage II Multiple Myeloma, Stage III Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2015-07-29